Transparency Indicators Stratified for Journal, Year, and Coronavirus Disease 2019 Status
| Journal, Year, and COVID-19 Status . | Total . | Code Sharing . | Data Sharing . | Registration . | Conflict of Interest . | Funding . |
|---|---|---|---|---|---|---|
| BMC Infect Dis 2019 | 907 | 7 (1) | 104 (11) | 84 (9) | 907 (100) | 907 (100) |
| BMC Infect Dis 2021 non-COVID-19 | 757 | 12 (2) | 78 (10) | 66 (9) | 757 (100) | 757 (100) |
| BMC Infect Dis 2021 COVID-19 | 292 | 9 (3) | 17 (6) | 27 (9) | 292 (100) | 292 (100) |
| BMC Infect Dis 2021 | 1049 | 21 (2) | 95 (9) | 93 (9) | 1049 (100) | 1049 (100) |
| Clin Infect Dis 2019 | 233 | 0 (0) | 11 (5) | 0 (0) | 233 (100) | 225 (97) |
| Clin Infect Dis 2021 non-COVID-19 | 248 | 5 (2) | 19 (8) | 48 (19) | 248 (100) | 236 (95) |
| Clin Infect Dis 2021 COVID-19 | 369 | 11 (3) | 10 (3) | 18 (5) | 343 (93) | 315 (85) |
| Clin Infect Dis 2021 | 617 | 16 (3) | 29 (5) | 66 (11) | 591 (96) | 551 (89) |
| Clin Microbiol Infect 2019 | 22 | 0 (0) | 2 (9) | 3 (14) | 20 (91) | 20 (91) |
| Clin Microbiol Infect 2021 non-COVID-19 | 11 | 0 (0) | 2 (18) | 1 (9) | 7 (64) | 10 (91) |
| Clin Microbiol Infect 2021 COVID-19 | 161 | 0 (0) | 7 (4) | 19 (12) | 116 (72) | 137 (85) |
| Clin Microbiol Infect 2021 | 172 | 0 (0) | 9 (5) | 20 (12) | 123 (72) | 147 (85) |
| Emerg Infect Dis 2019 | 354 | 5 (1) | 62 (18) | 3 (1) | 21 (6) | 243 (69) |
| Emerg Infect Dis 2021 non-COVID-19 | 306 | 1 (0) | 62 (20) | 1 (0) | 20 (7) | 186 (61) |
| Emerg Infect Dis 2021 COVID-19 | 252 | 8 (3) | 12 (5) | 2 (1) | 20 (8) | 160 (63) |
| Emerg Infect Dis 2021 | 558 | 9 (2) | 74 (13) | 3 (1) | 40 (7) | 346 (62) |
| Infect Immun 2019 | 57 | 1 (2) | 11 (19) | 0 (0) | 29 (51) | 56 (98) |
| Infect Immun 2021 non-COVID-19 | 50 | 1 (2) | 16 (32) | 1 (2) | 28 (56) | 50 (100) |
| Infect Immun 2021 COVID-19 | 0 | 0 | 0 | 0 | 0 | 0 |
| Infect Immun 2021 | 50 | 1 (2) | 16 (32) | 1 (2) | 28 (56) | 50 (100) |
| Int J Infect Dis 2019 | 35 | 0 (0) | 4 (11) | 1 (3) | 35 (100) | 35 (100) |
| Int J Infect Dis 2021 non-COVID-19 | 37 | 0 (0) | 4 (11) | 3 (8) | 36 (97) | 37 (100) |
| Int J Infect Dis 2021 COVID-19 | 513 | 12 (2) | 19 (4) | 22 (4) | 498 (97) | 499 (97) |
| Int J Infect Dis 2021 | 550 | 12 (2) | 23 (4) | 25 (5) | 534 (97) | 536 (97) |
| J Antimicrob Chemother 2019 | 86 | 1 (1) | 14 (16) | 9 (10) | 28 (33) | 84 (98) |
| J Antimicrob Chemother 2021 non-COVID-19 | 101 | 1 (1) | 13 (13) | 8 (8) | 42 (42) | 98 (97) |
| J Antimicrob Chemother 2021 COVID-19 | 25 | 0 (0) | 2 (8) | 3 (12) | 7 (28) | 23 (92) |
| J Antimicrob Chemother 2021 | 126 | 1 (1) | 15 (12) | 11 (9) | 49 (39) | 121 (96) |
| J Infect Dis 2019 | 125 | 3 (2) | 9 (7) | 21 (17) | 125 (100) | 125 (100) |
| J Infect Dis 2021 non-COVID-19 | 114 | 4 (4) | 6 (5) | 12 (11) | 114 (100) | 106 (93) |
| J Infect Dis 2021 COVID-19 | 143 | 4 (3) | 3 (2) | 13 (9) | 141 (99) | 138 (97) |
| J Infect Dis 2021 | 257 | 8 (3) | 9 (3) | 25 (10) | 255 (99) | 244 (95) |
| Lancet Infect Dis 2019 | 39 | 2 (5) | 2 (5) | 9 (23) | 39 (100) | 34 (87) |
| Lancet Infect Dis 2021 non-COVID-19 | 1 | 0 (0) | 0 (0) | 1 (100) | 1 (100) | 1 (100) |
| Lancet Infect Dis 2021 COVID-19 | 40 | 2 (5) | 2 (5) | 10 (25) | 40 (100) | 35 (88) |
| Lancet Infect Dis 2021 | 28 | 3 (11) | 4 (14) | 12 (43) | 28 (100) | 27 (96) |
| Journal, Year, and COVID-19 Status . | Total . | Code Sharing . | Data Sharing . | Registration . | Conflict of Interest . | Funding . |
|---|---|---|---|---|---|---|
| BMC Infect Dis 2019 | 907 | 7 (1) | 104 (11) | 84 (9) | 907 (100) | 907 (100) |
| BMC Infect Dis 2021 non-COVID-19 | 757 | 12 (2) | 78 (10) | 66 (9) | 757 (100) | 757 (100) |
| BMC Infect Dis 2021 COVID-19 | 292 | 9 (3) | 17 (6) | 27 (9) | 292 (100) | 292 (100) |
| BMC Infect Dis 2021 | 1049 | 21 (2) | 95 (9) | 93 (9) | 1049 (100) | 1049 (100) |
| Clin Infect Dis 2019 | 233 | 0 (0) | 11 (5) | 0 (0) | 233 (100) | 225 (97) |
| Clin Infect Dis 2021 non-COVID-19 | 248 | 5 (2) | 19 (8) | 48 (19) | 248 (100) | 236 (95) |
| Clin Infect Dis 2021 COVID-19 | 369 | 11 (3) | 10 (3) | 18 (5) | 343 (93) | 315 (85) |
| Clin Infect Dis 2021 | 617 | 16 (3) | 29 (5) | 66 (11) | 591 (96) | 551 (89) |
| Clin Microbiol Infect 2019 | 22 | 0 (0) | 2 (9) | 3 (14) | 20 (91) | 20 (91) |
| Clin Microbiol Infect 2021 non-COVID-19 | 11 | 0 (0) | 2 (18) | 1 (9) | 7 (64) | 10 (91) |
| Clin Microbiol Infect 2021 COVID-19 | 161 | 0 (0) | 7 (4) | 19 (12) | 116 (72) | 137 (85) |
| Clin Microbiol Infect 2021 | 172 | 0 (0) | 9 (5) | 20 (12) | 123 (72) | 147 (85) |
| Emerg Infect Dis 2019 | 354 | 5 (1) | 62 (18) | 3 (1) | 21 (6) | 243 (69) |
| Emerg Infect Dis 2021 non-COVID-19 | 306 | 1 (0) | 62 (20) | 1 (0) | 20 (7) | 186 (61) |
| Emerg Infect Dis 2021 COVID-19 | 252 | 8 (3) | 12 (5) | 2 (1) | 20 (8) | 160 (63) |
| Emerg Infect Dis 2021 | 558 | 9 (2) | 74 (13) | 3 (1) | 40 (7) | 346 (62) |
| Infect Immun 2019 | 57 | 1 (2) | 11 (19) | 0 (0) | 29 (51) | 56 (98) |
| Infect Immun 2021 non-COVID-19 | 50 | 1 (2) | 16 (32) | 1 (2) | 28 (56) | 50 (100) |
| Infect Immun 2021 COVID-19 | 0 | 0 | 0 | 0 | 0 | 0 |
| Infect Immun 2021 | 50 | 1 (2) | 16 (32) | 1 (2) | 28 (56) | 50 (100) |
| Int J Infect Dis 2019 | 35 | 0 (0) | 4 (11) | 1 (3) | 35 (100) | 35 (100) |
| Int J Infect Dis 2021 non-COVID-19 | 37 | 0 (0) | 4 (11) | 3 (8) | 36 (97) | 37 (100) |
| Int J Infect Dis 2021 COVID-19 | 513 | 12 (2) | 19 (4) | 22 (4) | 498 (97) | 499 (97) |
| Int J Infect Dis 2021 | 550 | 12 (2) | 23 (4) | 25 (5) | 534 (97) | 536 (97) |
| J Antimicrob Chemother 2019 | 86 | 1 (1) | 14 (16) | 9 (10) | 28 (33) | 84 (98) |
| J Antimicrob Chemother 2021 non-COVID-19 | 101 | 1 (1) | 13 (13) | 8 (8) | 42 (42) | 98 (97) |
| J Antimicrob Chemother 2021 COVID-19 | 25 | 0 (0) | 2 (8) | 3 (12) | 7 (28) | 23 (92) |
| J Antimicrob Chemother 2021 | 126 | 1 (1) | 15 (12) | 11 (9) | 49 (39) | 121 (96) |
| J Infect Dis 2019 | 125 | 3 (2) | 9 (7) | 21 (17) | 125 (100) | 125 (100) |
| J Infect Dis 2021 non-COVID-19 | 114 | 4 (4) | 6 (5) | 12 (11) | 114 (100) | 106 (93) |
| J Infect Dis 2021 COVID-19 | 143 | 4 (3) | 3 (2) | 13 (9) | 141 (99) | 138 (97) |
| J Infect Dis 2021 | 257 | 8 (3) | 9 (3) | 25 (10) | 255 (99) | 244 (95) |
| Lancet Infect Dis 2019 | 39 | 2 (5) | 2 (5) | 9 (23) | 39 (100) | 34 (87) |
| Lancet Infect Dis 2021 non-COVID-19 | 1 | 0 (0) | 0 (0) | 1 (100) | 1 (100) | 1 (100) |
| Lancet Infect Dis 2021 COVID-19 | 40 | 2 (5) | 2 (5) | 10 (25) | 40 (100) | 35 (88) |
| Lancet Infect Dis 2021 | 28 | 3 (11) | 4 (14) | 12 (43) | 28 (100) | 27 (96) |
Data are presented as No. (%). Bold fields indicate the groups and indicators in which a statistically significant result (P < .005) was found in a comparison against another group (2021 vs 2019, 2021 COVID-19 vs 2021 non-COVID-19, or 2019 vs 2021 non-COVID-19).
Abbreviation: COVID-19, coronavirus disease 2019.
Transparency Indicators Stratified for Journal, Year, and Coronavirus Disease 2019 Status
| Journal, Year, and COVID-19 Status . | Total . | Code Sharing . | Data Sharing . | Registration . | Conflict of Interest . | Funding . |
|---|---|---|---|---|---|---|
| BMC Infect Dis 2019 | 907 | 7 (1) | 104 (11) | 84 (9) | 907 (100) | 907 (100) |
| BMC Infect Dis 2021 non-COVID-19 | 757 | 12 (2) | 78 (10) | 66 (9) | 757 (100) | 757 (100) |
| BMC Infect Dis 2021 COVID-19 | 292 | 9 (3) | 17 (6) | 27 (9) | 292 (100) | 292 (100) |
| BMC Infect Dis 2021 | 1049 | 21 (2) | 95 (9) | 93 (9) | 1049 (100) | 1049 (100) |
| Clin Infect Dis 2019 | 233 | 0 (0) | 11 (5) | 0 (0) | 233 (100) | 225 (97) |
| Clin Infect Dis 2021 non-COVID-19 | 248 | 5 (2) | 19 (8) | 48 (19) | 248 (100) | 236 (95) |
| Clin Infect Dis 2021 COVID-19 | 369 | 11 (3) | 10 (3) | 18 (5) | 343 (93) | 315 (85) |
| Clin Infect Dis 2021 | 617 | 16 (3) | 29 (5) | 66 (11) | 591 (96) | 551 (89) |
| Clin Microbiol Infect 2019 | 22 | 0 (0) | 2 (9) | 3 (14) | 20 (91) | 20 (91) |
| Clin Microbiol Infect 2021 non-COVID-19 | 11 | 0 (0) | 2 (18) | 1 (9) | 7 (64) | 10 (91) |
| Clin Microbiol Infect 2021 COVID-19 | 161 | 0 (0) | 7 (4) | 19 (12) | 116 (72) | 137 (85) |
| Clin Microbiol Infect 2021 | 172 | 0 (0) | 9 (5) | 20 (12) | 123 (72) | 147 (85) |
| Emerg Infect Dis 2019 | 354 | 5 (1) | 62 (18) | 3 (1) | 21 (6) | 243 (69) |
| Emerg Infect Dis 2021 non-COVID-19 | 306 | 1 (0) | 62 (20) | 1 (0) | 20 (7) | 186 (61) |
| Emerg Infect Dis 2021 COVID-19 | 252 | 8 (3) | 12 (5) | 2 (1) | 20 (8) | 160 (63) |
| Emerg Infect Dis 2021 | 558 | 9 (2) | 74 (13) | 3 (1) | 40 (7) | 346 (62) |
| Infect Immun 2019 | 57 | 1 (2) | 11 (19) | 0 (0) | 29 (51) | 56 (98) |
| Infect Immun 2021 non-COVID-19 | 50 | 1 (2) | 16 (32) | 1 (2) | 28 (56) | 50 (100) |
| Infect Immun 2021 COVID-19 | 0 | 0 | 0 | 0 | 0 | 0 |
| Infect Immun 2021 | 50 | 1 (2) | 16 (32) | 1 (2) | 28 (56) | 50 (100) |
| Int J Infect Dis 2019 | 35 | 0 (0) | 4 (11) | 1 (3) | 35 (100) | 35 (100) |
| Int J Infect Dis 2021 non-COVID-19 | 37 | 0 (0) | 4 (11) | 3 (8) | 36 (97) | 37 (100) |
| Int J Infect Dis 2021 COVID-19 | 513 | 12 (2) | 19 (4) | 22 (4) | 498 (97) | 499 (97) |
| Int J Infect Dis 2021 | 550 | 12 (2) | 23 (4) | 25 (5) | 534 (97) | 536 (97) |
| J Antimicrob Chemother 2019 | 86 | 1 (1) | 14 (16) | 9 (10) | 28 (33) | 84 (98) |
| J Antimicrob Chemother 2021 non-COVID-19 | 101 | 1 (1) | 13 (13) | 8 (8) | 42 (42) | 98 (97) |
| J Antimicrob Chemother 2021 COVID-19 | 25 | 0 (0) | 2 (8) | 3 (12) | 7 (28) | 23 (92) |
| J Antimicrob Chemother 2021 | 126 | 1 (1) | 15 (12) | 11 (9) | 49 (39) | 121 (96) |
| J Infect Dis 2019 | 125 | 3 (2) | 9 (7) | 21 (17) | 125 (100) | 125 (100) |
| J Infect Dis 2021 non-COVID-19 | 114 | 4 (4) | 6 (5) | 12 (11) | 114 (100) | 106 (93) |
| J Infect Dis 2021 COVID-19 | 143 | 4 (3) | 3 (2) | 13 (9) | 141 (99) | 138 (97) |
| J Infect Dis 2021 | 257 | 8 (3) | 9 (3) | 25 (10) | 255 (99) | 244 (95) |
| Lancet Infect Dis 2019 | 39 | 2 (5) | 2 (5) | 9 (23) | 39 (100) | 34 (87) |
| Lancet Infect Dis 2021 non-COVID-19 | 1 | 0 (0) | 0 (0) | 1 (100) | 1 (100) | 1 (100) |
| Lancet Infect Dis 2021 COVID-19 | 40 | 2 (5) | 2 (5) | 10 (25) | 40 (100) | 35 (88) |
| Lancet Infect Dis 2021 | 28 | 3 (11) | 4 (14) | 12 (43) | 28 (100) | 27 (96) |
| Journal, Year, and COVID-19 Status . | Total . | Code Sharing . | Data Sharing . | Registration . | Conflict of Interest . | Funding . |
|---|---|---|---|---|---|---|
| BMC Infect Dis 2019 | 907 | 7 (1) | 104 (11) | 84 (9) | 907 (100) | 907 (100) |
| BMC Infect Dis 2021 non-COVID-19 | 757 | 12 (2) | 78 (10) | 66 (9) | 757 (100) | 757 (100) |
| BMC Infect Dis 2021 COVID-19 | 292 | 9 (3) | 17 (6) | 27 (9) | 292 (100) | 292 (100) |
| BMC Infect Dis 2021 | 1049 | 21 (2) | 95 (9) | 93 (9) | 1049 (100) | 1049 (100) |
| Clin Infect Dis 2019 | 233 | 0 (0) | 11 (5) | 0 (0) | 233 (100) | 225 (97) |
| Clin Infect Dis 2021 non-COVID-19 | 248 | 5 (2) | 19 (8) | 48 (19) | 248 (100) | 236 (95) |
| Clin Infect Dis 2021 COVID-19 | 369 | 11 (3) | 10 (3) | 18 (5) | 343 (93) | 315 (85) |
| Clin Infect Dis 2021 | 617 | 16 (3) | 29 (5) | 66 (11) | 591 (96) | 551 (89) |
| Clin Microbiol Infect 2019 | 22 | 0 (0) | 2 (9) | 3 (14) | 20 (91) | 20 (91) |
| Clin Microbiol Infect 2021 non-COVID-19 | 11 | 0 (0) | 2 (18) | 1 (9) | 7 (64) | 10 (91) |
| Clin Microbiol Infect 2021 COVID-19 | 161 | 0 (0) | 7 (4) | 19 (12) | 116 (72) | 137 (85) |
| Clin Microbiol Infect 2021 | 172 | 0 (0) | 9 (5) | 20 (12) | 123 (72) | 147 (85) |
| Emerg Infect Dis 2019 | 354 | 5 (1) | 62 (18) | 3 (1) | 21 (6) | 243 (69) |
| Emerg Infect Dis 2021 non-COVID-19 | 306 | 1 (0) | 62 (20) | 1 (0) | 20 (7) | 186 (61) |
| Emerg Infect Dis 2021 COVID-19 | 252 | 8 (3) | 12 (5) | 2 (1) | 20 (8) | 160 (63) |
| Emerg Infect Dis 2021 | 558 | 9 (2) | 74 (13) | 3 (1) | 40 (7) | 346 (62) |
| Infect Immun 2019 | 57 | 1 (2) | 11 (19) | 0 (0) | 29 (51) | 56 (98) |
| Infect Immun 2021 non-COVID-19 | 50 | 1 (2) | 16 (32) | 1 (2) | 28 (56) | 50 (100) |
| Infect Immun 2021 COVID-19 | 0 | 0 | 0 | 0 | 0 | 0 |
| Infect Immun 2021 | 50 | 1 (2) | 16 (32) | 1 (2) | 28 (56) | 50 (100) |
| Int J Infect Dis 2019 | 35 | 0 (0) | 4 (11) | 1 (3) | 35 (100) | 35 (100) |
| Int J Infect Dis 2021 non-COVID-19 | 37 | 0 (0) | 4 (11) | 3 (8) | 36 (97) | 37 (100) |
| Int J Infect Dis 2021 COVID-19 | 513 | 12 (2) | 19 (4) | 22 (4) | 498 (97) | 499 (97) |
| Int J Infect Dis 2021 | 550 | 12 (2) | 23 (4) | 25 (5) | 534 (97) | 536 (97) |
| J Antimicrob Chemother 2019 | 86 | 1 (1) | 14 (16) | 9 (10) | 28 (33) | 84 (98) |
| J Antimicrob Chemother 2021 non-COVID-19 | 101 | 1 (1) | 13 (13) | 8 (8) | 42 (42) | 98 (97) |
| J Antimicrob Chemother 2021 COVID-19 | 25 | 0 (0) | 2 (8) | 3 (12) | 7 (28) | 23 (92) |
| J Antimicrob Chemother 2021 | 126 | 1 (1) | 15 (12) | 11 (9) | 49 (39) | 121 (96) |
| J Infect Dis 2019 | 125 | 3 (2) | 9 (7) | 21 (17) | 125 (100) | 125 (100) |
| J Infect Dis 2021 non-COVID-19 | 114 | 4 (4) | 6 (5) | 12 (11) | 114 (100) | 106 (93) |
| J Infect Dis 2021 COVID-19 | 143 | 4 (3) | 3 (2) | 13 (9) | 141 (99) | 138 (97) |
| J Infect Dis 2021 | 257 | 8 (3) | 9 (3) | 25 (10) | 255 (99) | 244 (95) |
| Lancet Infect Dis 2019 | 39 | 2 (5) | 2 (5) | 9 (23) | 39 (100) | 34 (87) |
| Lancet Infect Dis 2021 non-COVID-19 | 1 | 0 (0) | 0 (0) | 1 (100) | 1 (100) | 1 (100) |
| Lancet Infect Dis 2021 COVID-19 | 40 | 2 (5) | 2 (5) | 10 (25) | 40 (100) | 35 (88) |
| Lancet Infect Dis 2021 | 28 | 3 (11) | 4 (14) | 12 (43) | 28 (100) | 27 (96) |
Data are presented as No. (%). Bold fields indicate the groups and indicators in which a statistically significant result (P < .005) was found in a comparison against another group (2021 vs 2019, 2021 COVID-19 vs 2021 non-COVID-19, or 2019 vs 2021 non-COVID-19).
Abbreviation: COVID-19, coronavirus disease 2019.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
